Oxidative stress-mediated brain dehydroepiandrosterone (DHEA) formation in Alzheimer's disease diagnosis

Frontiers in Endocrinology

Volumn 2, Issue NOV, 2011, Pages

  Rammouz, Georges ^a   Lecanu, Laurent ^a   Papadopoulos, Vassilios ^a,b  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Dehydroepiandrosterone; Diagnostic tool; Neurosteroids

Indexed keywords

EID: 84874363130     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00069     Document Type: Review

References (151)

1. Akwa, Y., Young, J., Kabbadj, K., Sancho, M. J., Zucman, D., Vourc'h, C., Jung-Testas, I., Hu, Z. Y., Le Goascogne, C., and Jo, D. H. (1991). Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. J. Steroid Biochem. Mol. Biol. 40, 71-81.
2. Alhaj, H. A., Massey, A. E., and McAllister-Williams, R. H. (2006). Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology (Berl.) 188, 541-551.
3. Araghiniknam, M., Chung, S., Nelson-White, T., Eskelson, C., and Watson, R. R. (1996). Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans. Life Sci. 59, L147-L157.
4. Aragno, M., Brignardello, E., Tamagno, E., Gatto, V., Danni, O., and Boccuzzi, G. (1997). Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. J. Endocrinol. 155, 233-240.
5. Arias, H. R., Bhumireddy, P., and Bouzat, C. (2006). Molecular mechanisms and binding site locations for noncompetitive antagonists of nico-tinic acetylcholine receptors. Int. J. Biochem. Cell Biol. 38, 1254-1276.
6. Austin, C., and Ellis, J. (2003). Microbial pathways leading to steroidal malodour in the axilla. J. Steroid Biochem. Mol. Biol. 87, 105-110.
7. Bastianetto, S., Ramassamy, C., Poirier, J., and Quirion, R. (1999). Dehy-droepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res. Mol. Brain Res. 66, 35-41.
8. Baulieu, E. E. (1981). Steroids Hormones in the Brain: Several Mechanisms? Oxford: Pergamon Press, 3-14.
9. Baulieu, E. E. (1996). Dehy-droepiandrosterone (DHEA): a fountain of youth? J. Clin. Endocrinol. Metab. 81, 3147-3151.
10. Baulieu, E. E. (1997). Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52, 1-32.
11. Baulieu, E. E. (1998). Neurosteroids: a novel function of the brain. Psy- choneuroendocrinology 23, 963-987.
12. Baulieu, E. E., Corpechot, C., Dray, F., Emiliozzi, R., Lebeau, M. C., Mauvais Jarvis, P., and Robel, P. (1965). An adrenal-selected "androgen": dehydroisoandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man. Recent Prog. Horm. Res. 21, 411-500.
13. Baulieu, E. E., and Robel, P. (1990). Neurosteroids: a new brain func- tion? J. Steroid Biochem. Mol. Biol. 37, 395-403.
14. Baulieu, E. E., and Robel, P. (1996). Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 150(Suppl.), S221-S239.
15. Baulieu, E. E., Robel, P., and Schumacher, M. (1999). Neurosteroids: A New Regulatory Function in the Nervous System. Totowa, NJ: Humana Press.
16. Beard, J. L., Connor, J. R., and Jones, B. C. (1993). Iron in the brain. Nutr. Rev. 51, 157-170.
17. Belelli, D., Herd, M. B., Mitchell, E. A., Peden, D. R., Vardy, A. W., Gentet, L., and Lambert, J. J. (2006). Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 138, 821-829.
18. Bergeron, R., de, Montigny, C., and Debonnel,G. (1996). Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neu- rosci. 16, 1193-1202.
19. Berr, C., Lafont, S., Debuire, B., Dartigues, J. F., and Baulieu, E. E. (1996). Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl. Acad. Sci. U.S.A. 93, 13410-13415.
20. Bitran, D., Foley, M., Audette, D., Leslie, N., and Frye, C. A. (2000). Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopreg- nanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl.) 151, 64-71.
21. Boccuzzi, G., Aragno, M., Seccia, M., Brignardello, E., Tamagno, E., Albano, E., Danni, O., and Bellomo, G. (1997). Protective effect of dehydroepiandrosterone against copperinduced lipid peroxidation in the rat. Free Radic. Biol. Med. 22,1289-1294.
22. Boon, W. C., McDougall, J. G., and Coghlan, J. P. (1998). Hypothesis: aldosterone is synthesized by an alternative pathway during severe sodium depletion. 'A new wine in an old bottle.' Clin. Exp. Pharmacol. Physiol. 25, 369-378.
23. Brown, R. C., Cascio, C., and Papadopoulos, V. (2000). Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J. Neurochem. 74, 847-859.
24. Brown, R. C., Han, Z., Cascio, C., and Papadopoulos, V. (2003). Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology. Neurobiol. Aging 24, 57-65.
25. Burns, A., and Iliffe, S. (2009). Alzheimer's disease. BMJ 338, b158.
26. Cascio, C., Brown, R. C., Liu, Y., Han, Z., Hales, D. B., and Papadopoulos, V. (2000). Pathways of dehy- droepiandrosterone formation in rat brain glia. J. Steroid Biochem. Mol. Biol. 75, 177-186.
27. Cascio, C., Prasad, V. V., Lin, Y. Y., Lieberman, S., and Papadopoulos, V. (1998). Detection of P450c17-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc. Natl. Acad. Sci. U.S.A. 95, 2862-2867.
28. Charalampopoulos, I., Alexaki, V. I., Tsatsanis, C., Minas, V., Dermitzaki, E., Lasaridis, I., Vardouli, L., Stournaras, C., Margioris, A. N., Castanas, E., and Gravanis, A. (2006). Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Ann. N. Y. Acad. Sci. 1088, 139-152.
29. Charalampopoulos, I., Tsatsanis, C., Dermitzaki, E., Alexaki, V. I., Castanas, E., Margioris, A. N., and Gravanis, A. (2004). Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 101, 8209-8214.
30. Cheney, D. L., Uzunov, D., Costa, E., and Guidotti, A. (1995). Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J. Neurosci. 15, 4641-4650.
31. Compagnone, N. A., Bulfone, A., Rubenstein, J. L., and Mellon, S. H. (1995). Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology 136, 5212-5223.
32. Compagnone, N. A., and Mellon, S. H. (1998). Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. U.S.A. 95, 4678-4683.
33. Corpechot, C., Robel, P., Axelson, M., Sjovall, J., and Baulieu, E. E. (1981). Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U.S.A. 78, 4704-4707.
34. Corpechot, C., Synguelakis, M., Talha, S., Axelson, M., Sjovall, J., Vihko, R., Baulieu, E. E., and Robel, P. (1983). Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270, 119-125.
35. Costa, E., Auta, J., Guidotti, A., Korneyev,A., and Romeo, E. (1994). The pharmacology of neurosteroidogenesis. J. Steroid Biochem. Mol. Biol. 49, 385-389.
36. Costa, E. T., Soto, E. E., Cardoso, R. A., Olivera, D. S., and Valenzuela, C. F. (2000). Acute effects of ethanol on kainate receptors in cultured hippocampal neurons. Alcohol. Clin. Exp. Res. 24, 220-225.
37. Covey, D. F., Evers, A. S., Mennerick, S., Zorumski, C. F., and Purdy, R. H. (2001). Recent developments in structure-activity relationships for steroid modulators of GABA(A) receptors. Brain Res. Brain Res. Rev. 37, 91-97.
38. Coyle, J. T., and Puttfarcken, P. (1993). Oxidative stress,glutamate,and neurodegenerative diseases. Science 262, 689-695.
39. Dubrovsky, B. (2006). Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol. Biochem. Behav. 84, 644-655.
40. Dubrovsky, B. O. (2005). Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 169-192.
41. Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., and Beyreuther, K. (1992). Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal- catalyzed oxidation. J. Biol. Chem. 267, 18210-18217.
42. Engel, S. R., and Grant, K. A. (2001). Neurosteroids and behavior. Int. Rev. Neurobiol. 46, 321-348.
43. Flood, J. F., Morley, J. E., and Roberts, E. (1992). Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. U.S.A. 89, 1567-1571.
44. Galey, J. B. (1997). Potential use of iron chelators against oxidative damage. Adv. Pharmacol. 38, 167-203.
45. ′-chlorodiazepam. Proc. Natl. Acad. Sci. U.S.A. 89, 5118-5122.
46. Guazzo, E. P., Kirkpatrick, P. J., Goodyer, I. M., Shiers, H. M., and Herbert, J. (1996). Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab. 81, 3951-3960.
47. Guo, Q., Christakos, S., Robinson, N., and Mattson, M. P. (1998). Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. U.S.A. 95, 3227-3232.
48. Guo, Q., Furukawa, K., Sopher, B. L., Pham, D. G., Xie, J., Robinson, N., Martin, G. M., and Mattson, M. P. (1996). Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8, 379-383.
49. Hauet, T.,Yao, Z. X., Bose, H. S., Wall, C. T.,Han,Z.,Li,W.,Hales,D. B.,Miller, W. L., Culty, M., and Papadopoulos, V. (2005). Peripheral-type benzodi-azepine receptor-mediated action of steroidogenic acute regulatory pro- tein on cholesterol entry into leydig cell mitochondria. Mol. Endocrinol. 19, 540-554.
50. Hawkins, E. G. E. (1949). The reac- tions of organic peroxides. Part I. 2-Phenyl-2-butyl hydroperoxide. J. Chem. Soc. 2076-2077.
51. Hawkins, E. G. E., and Young, D. P. (1950). Reactions of organic peroxides. Part V. Reaction of ferrous sul- phate with methylcyclopentyl and methylcyclohexyl hydroperoxides. J. Chem. Soc. 2804-2807.
52. He, L. M., Zhang, C. G., Zhou, Z., and Xu, T. (2003). Rapid inhibitory effects of corticosterone on calcium influx in rat dorsal root ganglion neurons. Neuroscience 116, 325-333.
53. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., and Butterfield, D. A. (1994). A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 3270-3274.
54. Horishita, T., Minami, K., Uezono, Y., Shiraishi, M., Ogata, J., Okamoto, T., Terada, T., and Sata, T. (2005). The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 371, 221-228.
55. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa,R. C.,Cuajungco,M. P.,Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999). The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616.
56. Iwata, M., Muneoka, K. T., Shirayama, Y., Yamamoto, A., and Kawahara, R. (2005). A study of a dendritic marker, microtubule-associated protein 2 (MAP-2), in rats neonatally treated neurosteroids, pregnenolone and dehydroepiandrosterone (DHEA). Neurosci. Lett. 386, 145-149.
57. Jang, M. K., Mierke, D. F., Russek, S. J., and Farb, D. H. (2004). A steroid modulatory domain on NR2B controls N-methyl-d-aspartate receptor proton sensitivity. Proc. Natl. Acad. Sci. U.S.A. 101, 8198-8203.
58. Jiang, P.,Yang, C. X.,Wang,Y. T., and Xu, T. L. (2006). Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat. Neuroscience 141, 2041-2050.
59. Joachim, C. L., and Selkoe, D. J. (1992). The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 6, 7-34.
60. Karishma, K. K., and Herbert, J. (2002). Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16, 445-453.
61. Kasa, P., Rakonczay, Z., and Gulya, K. (1997). The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52, 511-535.
62. Kimonides,V. G., Khatibi, N. H., Svend- sen,C. N.,Sofroniew,M.V.,and Herbert, J. (1998). Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95, 1852-1857.
63. Klegeris, A., and McGeer, P. L. (1997). Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 49, 229-235.
64. Klegeris, A., Walker, D. G., and McGeer, P. L. (1994). Activation of macrophages by Alzheimer beta amyloid peptide. Biochem. Biophys. Res. Commun. 199, 984-991.
65. Korneyev, A., Pan, B. S., Polo, A., Romeo, E., Guidotti, A., and Costa, E. (1993). Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J. Neurochem. 61, 1515-1524.
66. Kostowski, W., and Bienkowski, P. (1999). Discriminative stimulus effects of ethanol: neuropharmacological characterization. Alcohol 17, 63-80.
67. LaCagnin, L. B., Levitt, M., Bergstrom, J. M., and Colby, H. D. (1989). Inhi- bition of adrenocortical, mitochondrial and microsomal monooxygenases by SU-10'603, a steroid 17 alpha-hydroxylase inhibitor. J. Steroid Biochem. 33, 599-604.
68. Lacroix, C., Fiet, J., Benais, J. P., Gueux, B., Bonete, R., Villette, J. M., Gourmel, B., and Dreux, C. (1987). Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydrosepiandroterone and 17-hydroxyprogesterone in specific regions of human brain. J. Steroid Biochem. 28, 317-325.
69. Lapchak,P.A.,andAraujo,D. M. (2001). Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases. Int. Rev. Neurobiol. 46, 379-397.
70. Larroque, C., and Van Lier, J. E. (1986). Hydroperoxysterols as a probe for the mechanism of cytochrome P-450scc-mediated hydroxylation. Homolytic versus heterolytic oxygen-oxygen bond scission. J. Biol. Chem. 261, 1083-1087.
71. Laurine, E., Lafitte, D., Gregoire, C., Seree, E., Loret, E., Douillard, S., Michel, B., Briand, C., and Verdier, J. M. (2003). Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. J. Biol. Chem. 278, 29979-29986.
72. Le Goascogne, C., Sananes, N., Eychenne, B., Gouezou, M., Baulieu, E. E., and Robel, P. (1995). Androgen biosynthesis in the stomach: expression of cytochrome P450 17 alpha-hydroxylase/17,20-lyase messenger ribonucleic acid and protein, and metabolism of pregnenolone and progesterone by parietal cells of the rat gastric mucosa. Endocrinology 136, 1744-1752.
73. Liere, P., Pianos, A., Eychenne, B., Cambourg, A., Bodin, K., Griffiths, W., Schumacher, M., Baulieu, E. E., and Sjovall, J. (2009). Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key. J. Lipid Res. 50, 2430-2444.
74. Lipschitz, D. L., Crowley, W. R., Arm-strong,W. E.,and Bealer,S. L. (2005). Neurochemical bases of plasticity in the magnocellular oxytocin system during gestation. Exp. Neurol. 196, 210-223.
75. Liu, Y., Pocivavsek, A., and Papadopoulos, V. (2009). Dehy- droepiandrosterone formation is independent of cytochrome P450 17alpha-hydroxylase/17, 20 lyase activity in the mouse brain. J. Steroid Biochem. Mol. Biol. 115, 86-90.
76. Maayan, R., Touati-Werner, D., Ram, E., Galdor, M., and Weizman, A. (2005). Is brain dehydroepiandrosterone synthesis modulated by free radicals in mice? Neurosci. Lett. 377, 130-135.
77. Majewska, M. D. (1992). Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38, 379-395.
78. Maksay, G., Laube, B., and Betz, H. (2001). Subunit-specific modulation of glycine receptors by neurosteroids. Neuropharmacology 41, 369-376.
79. Mameli, M., Carta, M., Partridge, L. D., and Valenzuela, C. F. (2005). Neurosteroid-induced plasticity of immature synapses via retrograde modulation of presynaptic NMDA receptors. J. Neurosci. 25,2285-2294.
80. Mariani, E., Monastero, R., and Mecocci, P. (2007). Mild cognitive impairment: a systematic review. J. Alzheimers. Dis. 12, 23-35.
81. Markesbery, W. R. (1997). Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
82. Mathur, C., Prasad, V. V., Raju, V. S., Welch,M.,and Lieberman,S. (1993). Steroids and their conjugates in the mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 90, 85-88.
83. Maurice, T., Gregoire, C., and Espallergues, J. (2006). Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol. Biochem. Behav. 84, 581-597.
84. Maurice, T., Phan, V. L., Urani, A., Kamei, H., Noda,Y., and Nabeshima, T. (1999). Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharma- cological evidence and therapeutic opportunities. Jpn. J. Pharmacol. 81, 125-155.
85. Maurice, T., Roman, F. J., and Privat, A. (1996). Modulation by neuros- teroids of the in vivo (+)-[3H]SKF- 10,047 binding to sigma 1 receptors in the mouse forebrain. J. Neurosci. Res. 46, 734-743.
86. Maurice, T., Su, T. P., and Pri-vat, A. (1998). Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide- induced amnesia in mice through a common mechanism. Neuroscience 83, 413-428.
87. Mayo, W., George, O., Darbra, S., Bouyer, J. J., Vallee, M., Darnaudery, M., Pallares, M., Lemaire-Mayo, V., Le Moal, M., Piazza, P. V., and Abrous, N. (2003). Individual differences in cognitive aging: implication of pregnenolone sulfate. Prog. Neurobiol. 71, 43-48.
88. Mecocci, P., MacGarvey, U., and Beal, M. F. (1994). Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
89. Melcangi, R. C., and Panzica, G. C. (2006). Neuroactive steroids: old players in a new game. Neuroscience 138, 733-739.
90. Mellon, S. H. (2007). Neurosteroid reg- ulation of central nervous system development. Pharmacol. Ther. 116, 107-124.
91. Mellon, S. H., and Deschepper, C. F. (1993). Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 629, 283-292.
92. Mellon, S. H., Griffin, L. D., and Compagnone, N. A. (2001). Biosynthesis and action of neurosteroids. Brain Res. Brain Res. Rev. 37, 3-12.
93. Meyer, J. H., and Gruol, D. L. (1994). Dehydroepiandrosterone sulfate alters synaptic potentials in area CA1 of the hippocampal slice. Brain Res. 633, 253-261.
94. Mitchell, E. A., Gentet, L. J., Dempster, J.,and Belelli,D. (2007). GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids. J. Physiol. 583, 1021-1040.
95. Mitchell, E. A., Herd, M. B., Gunn, B. G., Lambert, J. J., and Belelli, D. (2008). Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease. Neurochem. Int. 52, 588-595.
96. Monnet, F. P., Mahe, V., Robel, P., and Baulieu, E. E. (1995). Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d- aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. U.S.A. 92, 3774-3778.
97. Murakami, K., Fellous, A., Baulieu, E. E., and Robel, P. (2000). Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly. Proc. Natl. Acad. Sci. U.S.A. 97, 3579-3584.
98. Nunomura, A., Perry, G., Pappolla, M. A., Friedland, R. P., Hirai, K., Chiba, S., and Smith, M. A. (2000). Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59, 1011-1017.
99. Owen, R. W., and Bilton, R. F. (1984). Bioconversion of lithocholic acid under anaerobic conditions by Pseudomonas sp. strain NCIB 10590. Appl. Environ. Microbiol. 48, 606-609.
100. Papadopoulos, V. (1993). Peripheral- type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 14, 222-240.
101. Papadopoulos, V., Guarneri, P., Kreuger, K. E., Guidotti, A., and Costa, E. (1992). Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 5113-5117.
102. Papadopoulos, V., Lecanu, L., Brown, R. C., Han, Z., and Yao, Z. X. (2006). Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138, 749-756.
103. Paradiso, K., Sabey, K., Evers, A. S., Zorumski, C. F., Covey, D. F., and Steinbach, J. H. (2000). Steroid inhibition of rat neuronal nicotinic alpha4beta2 receptors expressed in HEK 293 cells. Mol. Pharmacol. 58, 341-351.
104. Parker, C. R. Jr. (1999). Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64, 640-647.
105. Parton, R. F., Vankelecom, I. F., Cas-selman, M. J., Bezoukhanova, C. P., Uytterhoeven, J. B., and Jacobs, P. A. (1994). An efficient mimic of cytochrome P-450 from a zeoliteencaged iron complex in a polymer membrane. Nature 370, 541-544.
106. Pereira, E. F., Hilmas, C., Santos, M. D., Alkondon, M., Maelicke, A., and Albuquerque, E. X. (2002). Unconventional ligands and modulators of nicotinic receptors. J. Neurobiol. 53, 479-500.
107. Plassart-Schiess, E., and Baulieu, E. E. (2001). Neurosteroids: recent find- ings. Brain Res. Brain Res. Rev. 37, 133-140.
108. Prasad, V. V., Vegesna, S. R., Welch, M., and Lieberman, S. (1994). Precursors of the neurosteroids. Proc. Natl. Acad. Sci. U.S.A. 91, 3220-3223.
109. Rammouz, G, Lecanu, L., Aisen, P., and Papadopoulos, V. (2011). A lead study on oxidative stress-mediate dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease. J. Alzheimers Dis. 24(Suppl. 2), 5-16.
110. Rhodes,M. E.,Li,P. K.,Burke,A. M.,and Johnson, D. A. (1997). Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 773, 28-32.
111. Robel, P., and Baulieu, E. E. (1985). Neuro-steroids: 3?-hydroxy-?(5)- derivatives in the rodent brain. Neurochem. Int. 7, 953-958.
112. Robel,P.,and Baulieu,E. E. (1994). Neurosteroids biosynthesis and function. Trends Endocrinol. Metab. 5, 1-8.
113. Robel, P., Synguelakis, M., Halberg, F., and Baulieu,E. E. (1986). Persistence of the circadian rhythm of dehydroepiandrosterone in the brain, but not in the plasma, of castrated and adrenalectomized rats. C. R. Acad. Sci. III Sci. Vie 303, 235-238.
114. Roberts, E., Bologa, L., Flood, J. F., and Smith, G. E. (1987). Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res. 406, 357-362.
115. Rone, M. B., Fan, J., and Papadopoulos, V. (2009). Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim. Biophys. Acta 1791, 646-658.
116. Rupprecht, R., di Michele, F., Hermann, B., Strohle, A., Lancel, M., Romeo, E.,and Holsboer,F. (2001). Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Brain Res. Rev. 37, 59-67.
117. Rupprecht, R., and Holsboer, F. (2001). Neuroactive steroids in neuropsychopharmacology. Int. Rev. Neurobiol. 46, 461-477.
118. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., and Schumacher, M. (2010). Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971-988.
119. Sanne, J. L., and Krueger, K. E. (1995). Aberrant splicing of rat steroid 17 alpha-hydroxylase transcripts. Gene 165, 327-328.
120. Sawyer, D. T., Liu, X., Redman, C., and Chong, B. (1994). Iron(II)/reductant(DH2)-induced activation of dioxygen for the hydroxylation and ketonization of hydrocarbons; mimics for the cytochrome P-450 hydroxylase/reductase system. Bioorg. Med. Chem. 2, 1385-1395.
121. Schiess, A. R., and Partridge, L. D. (2005). Pregnenolone sulfate acts through a G-protein-coupled sigma1-like receptor to enhance short term facilitation in adult hippocampal neurons. Eur. J. Pharmacol. 518, 22-29.
122. Schumacher, M., Akwa, Y., Guennoun, R., Robert, F., Labombarda, F., Desarnaud, F., Robel, P., De Nicola, A. F., and Baulieu, E. E. (2000). Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29, 307-326.
123. Schumacher, M., Guennoun, R., Robert, F., Carelli, C., Gago, N., Ghoumari, A., Gonzalez Deniselle, M. C., Gonzalez, S. L., Ibanez, C., Labombarda, F., Coirini, H., Baulieu, E. E., and De Nicola, A. F. (2004). Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. IGF. Res. 14(Suppl. A), S18-S33.
124. Shannon, E. E., Porcu, P., Purdy, R. H., and Grant, K. A. (2005). Char-acterization of the discriminative stimulus effects of the neuroactive steroid pregnanolone in DBA/2J and C57BL/6J inbred mice. J. Pharmacol. Exp. Ther. 314, 675-685.
125. Singh, M. (2006). Progesterone-induced neuroprotection. Endocrine 29, 271-274.
126. Smith, M. A., Harris, P. L., Sayre, L. M., and Perry, G. (1997). Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 94, 9866-9868.
127. Smith, M. A., Rudnicka-Nawrot, M., Richey, P. L., Praprotnik, D., Mulvihill, P., Miller, C. A., Sayre, L. M., and Perry, G. (1995). Carbonyl- related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64, 2660-2666.
128. Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., and Perry, G. (1994). Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. U.S.A. 91, 5710-5714.
129. Steffensen, S. C., Jones, M. D., Hales, K., and Allison, D. W. (2006). Dehydroepiandrosterone sulfate and estrone sulfate reduce GABA-recurrent inhibition in the hippocampus via muscarinic acetylcholine receptors. Hippocampus 16, 1080-1090.
130. Stocco, D. M., and Clark, B. J. (1996). Regulation of the acute production of steroids in steroidogenic cells. Endocr. Rev. 17, 221-244.
131. Stromstedt, M., and Waterman, M. R. (1995). Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Brain Res. Mol. Brain Res. 34, 75-88.
132. Strous, R. D., Maayan, R., and Weizman, A. (2006). The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur. Neuropsychopharmacol. 16, 155-169.
133. Subbarao, K. V., Richardson, J. S., and Ang, L. C. (1990). Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
134. Sullivan, S. D., and Moenter, S. M. (2003). Neurosteroids alter gamma- aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: a possible mechanism for direct steroidal control. Endocrinology 144, 4366-4375.
135. Suzuki, M., Wright, L. S., Marwah, P., Lardy, H. A., and Svendsen, C. N. (2004). Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc. Natl. Acad. Sci. U.S.A. 101, 3202-3207.
136. Takebayashi, M., Hayashi, T., and Su, T. P. (2004). A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors. Pharmacopsychiatry 37(Suppl. 3), S208-S213.
137. Tan,L.,and Rousseau,J. (1975).Anaerobic degradation of the progesterone side chain: a possible new pathway for the biosynthesis of androgen hormones. Biochem. Biophys. Res. Commun. 65, 1320-1326.
138. Tasker, J. G. (2006). Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration. Obesity (Silver Spring) 14(Suppl. 5), 259S-265S.
139. Torres, J. M., and Ortega, E. (2003). DHEA, PREG and their sulphate derivatives on plasma and brain after CRH and ACTH administration. Neurochem. Res. 28, 1187-1191.
140. Trapani, G., Laquintana, V., Denora, N., Trapani, A., Lopedota, A., Latrofa, A., Franco, M., Serra, M., Pisu, M. G., Floris, I., Sanna, E., Biggio, G., and Liso, G. (2005). Structure-activity relationships and effects on neuroactive steroid synthesis in a series of 2-phenylimidazo[1,2- a]pyridineacetamide peripheral benzodiazepine receptors ligands. J. Med. Chem. 48, 292-305.
141. Ueda, H., Inoue, M., Yoshida, A., Mizuno, K., Yamamoto, H., Maruo, J., Matsuno, K., and Mita, S. (2001). Metabotropic neurosteroid/sigmareceptor involved in stimulation of nociceptor endings of mice. J. Pharmacol. Exp. Ther. 298, 703-710.
142. Vallee, M., Mayo, W., Darnaudery, M., Corpechot, C., Young, J., Koehl, M., Le Moal, M., Baulieu, E. E., Robel, P., and Simon, H. (1997). Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 94, 14865-14870.
143. Vallee, M., Mayo, W., and Le Moal, M. (2001). Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res. Brain Res. Rev. 37, 301-312.
144. Van Lier, J. E., and Smith, L. L. (1970). Sterol metabolism. XVI. Choles-terol 20-alpha-hydroperoxide as an intermediate in pregnenolone biosynthesis from cholesterol. Biochem. Biophys. Res. Commun. 40, 510-516.
145. Wang, J. M., Johnston, P. B., Ball, B. G., and Brinton, R. D. (2005). The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 25, 4706-4718.
146. Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., and Liu, Y. (2001). Estrogens: trophic and protective factors in the adult brain. Front. Neuroendocrinol. 22, 33-66.
147. Wolf, O. T., Koster, B., Kirschbaum, C., Pietrowsky, R., Kern, W., Hell-hammer, D. H., Born, J., and Fehm, H. L. (1997). A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol. Psychiatry 42, 845-848.
148. Wolf, O. T., Neumann, O., Hellhammer, D. H., Geiben, A. C., Strasburger, C. J., Dressendorfer, R. A., Pirke, K. M., and Kirschbaum, C. (1997). Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 82, 2363-2367.
149. Yanase, T. (1995). 17 alpha-Hydroxylase/17,20-lyase defects. J. Steroid Biochem. Mol. Biol. 53, 153-157.
150. Yoo, A., Harris, J., and Dubrovsky, B. (1996). Doseresponse study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp. Neurol. 137, 151-156.
151. Zhu, Y., Bond, J., and Thomas, P. (2003). Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl. Acad. Sci. U.S.A. 100, 2237-2242.